New study by Eric Rios-Doria et al. on early-stage endometrioid endometrial cancer

Memorial Sloan Kettering Radiation Oncology shared a post on X:

“New in IJGC:

In this cohort of patients with early-stage endometrioid endometrial cancer and isolated tumor cells (ITCs) vs true node-negative disease, those with ITC had a less favorable path and got more adjuvant therapy with similar survival.”